Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

AstraZeneca announces positive results from SOLO-3 trial of Lynparza

pharmaceutical-technologyDecember 21, 2018

Tag: AstraZeneca , Lynparza , SOLO-3 trial , BRCA-Mutated

PharmaSources Customer Service